Lenvatinib mesylate, CAS [[857890-39-2]]

Produktübersicht

• Artikelname: Lenvatinib mesylate, CAS [[857890-39-2]]
• Artikelnummer: BYT-ORB1298850
• Hersteller Artikelnummer: orb1298850
• Alternativnummer: BYT-ORB1298850-10, BYT-ORB1298850-100, BYT-ORB1298850-200, BYT-ORB1298850-25, BYT-ORB1298850-50, BYT-ORB1298850-500
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Vascular endothelial growth factor receptor, VEGFR, VEGFR1, VEGFR3, RET, SCFR, PDGFR, PDGFRalpha, PDGFRbeta, Inhibitor, inhibit, Platelet-derived growth factor receptor, FGFR1, FGFR, Fibroblast growth factor receptor, E7080 (mesylate), E7080, E-7080, Lenvatinib, Lenvatinib mesylate, Lenvatinib Mesylate, CD117, c-Kit, cKit, cRET, E 7080

Produktbeschreibung

Lenvatinib mesylate is an orally bioavailable, multi-targeted tyrosine kinase inhibitor that potently suppresses VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET. It is widely used in preclinical in vitro and in vivo studies for investigating angiogenesis, tumor growth, and metastasis in various cancer models.

Produkteigenschaften

• Molekulargewicht: 522.96
• Reinheit: 99.79% (May vary between batches)
• CAS Nummer: [857890-39-2]
• Formel: C22H23ClN4O7S
• Target-Kategorie: PDGFR,FGFR,c-Kit,c-RET,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.82 mM),DMSO:32.67 mg/mL (62.47 mM)